dibenzylchlorethamine has been researched along with Myotonic Dystrophy in 1 studies
Dibenzylchlorethamine: An alpha adrenergic antagonist.
Myotonic Dystrophy: Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fairhurst, AS | 1 |
| Lorenzen, L | 1 |
| Reavie, D | 1 |
1 other study available for dibenzylchlorethamine and Myotonic Dystrophy
| Article | Year |
|---|---|
Altered tracheal smooth muscle activities in an animal model of human myotonic dystrophy.
Topics: Animals; Carbachol; Cholesterol; Diazonium Compounds; Dibenzylchlorethamine; Disease Models, Animal; | 1976 |